Like the sTRU subtype, the EGFR/TP53 subtype was associated with younger age (mean age 59.1 vs. 64.5 years, p < 0.001), Asian race/ethnicity (18.9% vs. 6.3%, p < 0.001), never-smoker status (55.4% vs. 27.6%, p < 0.001), and smaller tumors (mean tumor size 3.27 cm vs. 3.96 cm, p = 0.042). This evidence concerns the gene EGFR and neoplasm.